Scientists have successfully used an advanced CRISPR gene-editing technique to repair a genetic defect in human embryos that causes a fatal heart condition. The procedure corrected the mutation in 85 percent of treated embryos without detectable off-target effects. While clinical application remains years away, the results are being hailed as a major milestone.